ADC Biotechnology

Activities: Research & Development Pharmaceutical

Trending Articles

  1. IFF Pharma Solutions launches customer experience platform, AnswerCenter AnswerCenter is part of IFF's ongoing digitalisation initiative, allowing customers to easily access tailored pharmaceutical excipient solutions
  2. You need to be a subscriber to read this article.
    Click here to find out more.
    Why quality control should be intimately combined with sterile product development, manufacturing and the overall product supply chain With sponsor companies increasingly needing to create and launch differentiated, stable, usable and safe injectable treatments for patients, experts at ten23 health are keen to...
  3. Novo Nordisk invests DKK 8.5bn into new Danish modular production site This is the first time this century that Novo Nordisk has invested into its Danish production capabilities, with the site being capable of manufacturing product types within...
  4. Bayer's acoramidis recommended for approval by the EMA's CHMP for cardiomyopathy The orally administered transthyretin (TTR) stabiliser is suitable for patients with transthyretin amyloid cardiomyopathy, demonstrating at least a 90% TTR stabilisation...
  5. TekniPlex Healthcare to showcase expanded capacity and sustainability solutions at Pharmapack Company highlights EU-based advancements in injection blow molding, multilayer blown films, and sustainable blister packaging

Upcoming event

EMPQ Essentials and Real-World Strategies for Successful Cleanroom Qualifications

16 January 2025 | Virtual See all

Related Content

Finance

Sterling Pharma Solutions acquires ADC Bio

This news follows an announcement by Sterling in December of a strategic investment into the ADC Bio business, with a view to acquisition in 2021
Design & Build

WHP completes cleanroom project for ADC Bio in the UK

The GMP facility in North Wales features Grade C and D cleanrooms and four-zone HVAC systems
Research & Development

ADC Bio secures additional equity round investment

Extra funding for strategic move into downstream formulation, fill-finish capabilities and full exploitation of Lock-Release as new ADC manufacturing paradigm
Ingredients

ADCs need more efficient manufacturing processes

Welsh ADC Biotechnology, a company working to simplify and lower production costs for anti-cancer blockbuster drugs, commented that "process innovation needs to be undertaken in the early R&D phase"
Finance

ADC Bio secures investment from Downing

The biotechnology company secured £1.14 million to finance bioconjuation and US expansion
Research & Development

ADC Bio developing downstream bioconjugation process

ADC Biotechnology is developing a downstream bioconjugation method, to present a new paradigm in antibody drug conjugate development and manufacturing
Estates & Facilities

WHP to build anti-cancer drug facility for ADC Bio

Multi-disciplined engineering specialist, WHP announces signing of partnership agreement with ADC Biotechnology (ADC Bio) to construct an anti-cancer drug manufacturing facility in Deeside, North Wales
Subscribe now